Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Jon Van der Walt"'
Publikováno v:
Haematologica, Vol 97, Iss 3 (2012)
Externí odkaz:
https://doaj.org/article/26f1efad9dd8457c8815884e03390be4
Written by global experts, this indispensable guide includes over 200 illustrations and essential information in clear tabular formatting, giving hematopathologists rapid access to diagnostic criteria at the microscope. General principles of bone mar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::235571f5043de48a91390c479ebb5959
https://doi.org/10.1017/9781316535042
https://doi.org/10.1017/9781316535042
Autor:
Roos J. Leguit, Markus Kremer, Umberto Gianelli, Alexandar Tzankov, Konnie M. Hebeda, Jon van der Walt, Attilio Orazi
Publikováno v:
Annals of Hematology, 97, 11, pp. 2117-2128
Annals of Hematology
Annals of Hematology, 97, 2117-2128
Annals of Hematology, 97(11), 2117. Springer Verlag
Annals of Hematology
Annals of Hematology, 97, 2117-2128
Annals of Hematology, 97(11), 2117. Springer Verlag
The bone marrow is a preferential site for both reactive and neoplastic histiocytic proliferations. The differential diagnosis ranges from reactive histiocyte hyperplasia in systemic infections, vaccinations, storage diseases, post myeloablative ther
Autor:
Joan Enric Ramis-Zaldivar, Itziar Salaverria, Alba Navarro, Stefan Dojcinov, Janine Schmidt, José Cabeçadas, Teresa Marafioti, Elaine S. Jaffe, Blanca Gonzalez-Farre, Ivonne A. Montes-Mojarro, Andreas Rosenwald, Jon van der Walt, Leticia Quintanilla-Martinez, Falko Fend, Caoimhe Egan, Elias Campo, German Ott, Ferran Nadeu, Irina Bonzheim
Publikováno v:
Blood. 130:323-327
Pediatric-type follicular lymphoma (PTFL) is a B-cell lymphoma with distinctive clinicopathological features. Recently, recurrent genetic alterations of potential importance for its pathogenesis that disrupt pathways associated with the germinal cent
Autor:
Marcus Kremer, Roos J. Leguit, Umberto Gianelli, Alexandar Tzankov, Konnie M. Hebeda, Attilio Orazi, Jon van der Walt
Publikováno v:
Pathobiology, 87, 1, pp. 2-19
Pathobiology, 87, 2-19
Pathobiology, 87(1), 2. S. Karger AG
Pathobiology, 87, 2-19
Pathobiology, 87(1), 2. S. Karger AG
Contains fulltext : 219909.pdf (Publisher’s version ) (Open Access) Most cases of mastocytosis are indolent, usually cutaneous mastocytosis or indolent systemic mastocytosis (SM). Aggressive mast cell (MC) diseases are very rare and often fatal. Th
Autor:
Vanesa Pérez-Alonso, Blanca Gonzalez-Farre, Stefan Dojcinov, German Ott, Teresa Marafioti, Roland Penzel, Olga Balagué, Carmen Lome-Maldonado, Carmen Bárcena, Volker Endris, Guillem Clot, Caoimhe Egan, Elias Campo, Joan Enric Ramis-Zaldivar, Andreas Rosenwald, Barbara Mankel, Jon van der Walt, Itziar Salaverria, Irina Bonzheim, Elaine S. Jaffe, Janine Schmidt, Ana Mozos, Ferran Nadeu, Leticia Quintanilla-Martinez, José Cabeçadas, Shunyou Gong, Falko Fend, Daniela Hoehn
Publikováno v:
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Pediatric-type follicular lymphoma (PTFL) is a variant of follicular lymphoma (FL) with distinctive clinicopathological features. Patients are predominantly young males presenting with localized lymphadenopathy; the tumor shows high-grade cytology an
Publikováno v:
Histopathology. 69:349-373
Small B cell lymphoid neoplasms are the most common lymphoproliferative disorders involving peripheral blood (PB) and bone marrow (BM). The Bone Marrow Workshop (BMW) organized by the European Bone Marrow Working Group (EBMWG) of the European Associa
Autor:
Jon van der Walt
Publikováno v:
Diagnostic Histopathology. 21:190-197
BCR-ABL 1 negative myeloproliferative neoplasms (MPN) are clonal haemopoietic stem cell disorders, characterized by proliferation of one or more of the myeloid cell lineages. Classification is based on the genetic abnormalities involved in the pathog
Autor:
Sanjay Sharma, Paul I. Dargan, John R. H. Archer, Alfonso Lostia, Nicola Drake, Andrew T. Kicman, Katherine Henderson, Jon van der Walt, David M. Wood, Christopher J. Walker
Publikováno v:
Drug Testing and Analysis. 7:433-438
Keywords: 1,3 dimethylamylamine (DMAA); sports supplement; Marathon; fatality; 4-methylhexane-2-amine; recreational drug